An infectious disease expert says the hantavirus cruise ship outbreak will likely fade in weeks, noting transmission of this illness is far less efficient than COVID.

Nearly 40 passengers disembarked from a cruise ship exposed to a deadly hantavirus outbreak and are believed to have dispersed across multiple countries untraced.

Fitness trainer Kenny Santucci shares his best summer fitness advice, including finding exercises you enjoy and focusing on consistency over strict workout programming.

The looksmaxxing trend has young men pursuing extreme physical changes online, raising concerns from experts about safety and mental health risks.

New ACP guidance suggests starting mammograms at 50 instead of 40 for average-risk women, one every two years, sparking debate among breast cancer screening experts.

A Swiss man who traveled on the MV Hondius cruise ship has tested positive for the Andes hantavirus strain and been isolated, officials confirmed.

WHO investigates a hantavirus outbreak on a cruise ship that left three dead, as experts weigh how the rodent-borne disease spread in close quarters.

A medical drone program in Missouri aims to speed up delivery of blood and lab samples, as rural patients face growing challenges accessing timely care.

New research finds obstructive sleep apnea is associated with higher muscle mass index but lower muscle density, signaling possible metabolic dysfunction.

Travel blogger Jake Rosmarin shares his experience trapped aboard the M/V Hondius during a hantavirus outbreak that has killed three passengers.

Dr. Mike Varshavaski warns about IV therapy risks and unregulated peptides, while supporting creatine as a supplement with real evidence behind it.

The WHO says rare human-to-human hantavirus transmission may have occurred aboard a cruise ship where three passengers died and four were sickened.

New blood tests measuring p-tau217 levels show promise for predicting Alzheimer's risk years before symptoms appear, though validation is still needed.

Every participant in a new bowel cancer immunotherapy trial remained cancer-free nearly three years after receiving pembrolizumab before surgery.